Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- befree-2016 importedOn "2016-02-19" NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion wasGeneratedBy ECO_0000203 NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion wasDerivedFrom befree-2016 NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion SIO_000772 22710719 NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion evidence source_evidence_literature NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.
- NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_assertion description "[The CML is nowadays successfully treated with BCR-ABL kinase inhibitors as imatinib and dasatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991120.RAdI2ZtMpaN2CoRgfeuoaWOgaVn28FpK3C8Yn4OUgWLzc130_provenance.